管理耐药高血压:一项案例研究探讨了ACE和ACTN3基因多态化的影响
Benedikt Gasser1, Alain Dössegger2, Martin Flück2,3
1Fernfachhochschule Schweiz, Scuola Universitaria Professionale Della Svizzera Italiana SUPSI, Manno, 6928, Switzerland.
Pharmacogenomics and personalized medicine
|December 26, 2025
概括
一位老年患者的高血压治疗以遗传洞察为指导. 个性化抗高血压药物,由ACE和ACTN3基因多态化告知,在其他药物失败时成功管理紧急情况.
科学领域:
- 药物基因组学 药物基因组学
- 心血管生理学心血管生理学
- 运动医学 运动医学
背景情况:
- 患者对抗高血压药物的反应有很大的不同.
- 血流调节涉及复杂的脏和肌肉过程,受遗传学影响.
- 高血压紧急情况可能发生在体力活动期间,特别是在老年人中.
研究的目的:
- 介绍一个关于老年女性患者管理高血压紧急情况的案例研究.
- 研究基因多态化在指导抗高血压治疗中的作用.
- 探索肌肉纤维类型与高血压管理之间的联系.
主要方法:
- 一个老年女性患者的病例报告经历了高血压紧急情况.
- 由于副作用或缺乏疗效,停止使用各种血管酶转化酶 (ACE) 抑制剂.
- 对ACE和ACTN3基因多态的基因定型.
- 根据遗传发现和患者反应进行治疗调整.
主要成果:
- 标准的ACE抑制剂治疗是无效的或引起严重的副作用.
- 患者的ACTN3-RR基因型表明,快肌肉纤维的比例更高.
- 一种基于遗传信息选择的β-阻断剂,有效地管理了高血压紧急情况.
- 患者报告说,仅使用β-阻断剂就能充分控制高血压.
结论:
- 遗传信息,特别是ACE和ACTN3多态,可以帮助选择最佳的抗高血压治疗方法.
- 个性化医疗方法对于管理高血压至关重要,特别是在老年人群中.
- 了解肌肉生理学的遗传基础可以为心血管药物选择提供信息.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437
Hypertension V: Nursing Management
332
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
332
Hypertension II: Pathophysiology
700
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
700


